New Insights into Cold Shock Proteins Effects in Human Cancer: Correlation with Susceptibility, Prognosis and Therapeutical Perspectives

Curr Med Chem. 2022;29(38):5965-5978. doi: 10.2174/0929867329666220601142924.

Abstract

The microenvironment of the tumor cells is central to its phenotypic modification. One of the essential elements of this milieu is thermal regulation. An augment in local temperature has been reported to augment the tumor cell's responsiveness to chemoand radiation treatment. Cold shock proteins are RNA/DNA binding proteins identified by the existence of one or more cold shock domains. In humans, the best studied components of this group of proteins are called Y-box binding proteins, such as Y-box binding protein-1 (YB-1), but several other proteins have been recognized. Biological functions of these proteins extend from the control of transcription, translation and splicing to the regulation of exosomal RNA content. Several findings correlate an altered cold shock protein expression profile with tumor diseases. In this review we summarize the data for a causative participation of cold shock proteins in cancer onset and diffusion. Furthermore, the possible use of cold shock proteins for diagnostics, prognosis, and as targets for cancer treatment is exposed.

Keywords: Cold shock protein; cancer; microRNA; prognosis; thermal stress; tumoral microenvironment.

Publication types

  • Review

MeSH terms

  • Cold Shock Proteins and Peptides* / metabolism
  • DNA-Binding Proteins / metabolism
  • Humans
  • Neoplasms* / diagnosis
  • Neoplasms* / therapy
  • Prognosis
  • RNA
  • RNA-Binding Proteins / chemistry
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism

Substances

  • Cold Shock Proteins and Peptides
  • DNA-Binding Proteins
  • RNA-Binding Proteins
  • RNA